Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/19/2012WO2011122916A3 Composition for increasing trail sensitivity, containing an inhibitor for inhibiting the expression or activity of tip41 which is a trail sensitizer target gene
04/19/2012WO2011116161A3 Arylsulfonamide ccr3 antagonists
04/19/2012WO2011115810A3 Isoform-specific rnai based on codon redundancy/degeneracy
04/19/2012WO2011113030A3 Human cancer micro-rna expression profiles predictive of chemo-response
04/19/2012WO2011109384A3 Biodegradable polymers for lowering intraocular pressure
04/19/2012WO2011104588A3 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
04/19/2012WO2011103586A9 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine
04/19/2012WO2011101114A3 An inhalable pharmaceutical composition
04/19/2012WO2011091205A3 Intracameral sustained release therapeutic agent implants
04/19/2012WO2011077098A9 Inhibitors of akt activity
04/19/2012WO2011067189A3 Cmet inhibitors for treating endometriosis
04/19/2012WO2011044501A9 Antibacterial aminoglycoside analogs
04/19/2012WO2011036561A8 Process
04/19/2012WO2011031855A3 Implantable device for controlled drug delivery
04/19/2012WO2011031621A8 High strength seamless alginate capsules
04/19/2012US20120095558 Synthetic bone grafts constructed from carbon foam materials
04/19/2012US20120095455 Photochemical tissue bonding
04/19/2012US20120095444 Polynucleotides encoding a human trim-cyp fusion polypeptide, compositions thereof, and methods of using same
04/19/2012US20120095418 Self-Supporting Films For Delivery Of Therapeutic Agents
04/19/2012US20120095388 Material for facilitating thermal treatments of biological tissues and method of energy targeting leading to thermal treatment of biological tissues
04/19/2012US20120095386 Composition and device structure for iontophoresis
04/19/2012US20120095277 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
04/19/2012US20120095235 Thioflavin derivates for use in the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
04/19/2012US20120095108 Composition containing microbial zeaxanthin and preparation thereof
04/19/2012US20120095107 Methods for treatment of cardiovascular disorders and diseases
04/19/2012US20120095106 Preparation of chiral amides and amines
04/19/2012US20120095105 Inhibitors of cognitive decline
04/19/2012US20120095104 Use of vasoconstrictors
04/19/2012US20120095103 Compounds for treating proliferative disorders
04/19/2012US20120095102 Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof
04/19/2012US20120095101 Aqueous intraocular penetration-promoting eye drop
04/19/2012US20120095100 Use of a combination of d-aspartic and l-aspartic acids or salts thereof for the treatment of male infertility
04/19/2012US20120095099 Trans carotenoids, their synthesis, formulation and uses
04/19/2012US20120095098 Bioavailability Enhancement Delivery System
04/19/2012US20120095097 Ophthalmic composition
04/19/2012US20120095096 2-oxamide inhibitors of phospholipase a2 activity and cellular arachidonate release based on dipeptides and pseudopeptides
04/19/2012US20120095095 Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
04/19/2012US20120095093 Antifungal compounds
04/19/2012US20120095092 Amide derivatives of benzene-sulfonanilide, pharmaceutical composition thereof and method for cancer treatment using the same
04/19/2012US20120095091 Antiepileptic, hypocholesterolemic and neuroprotective compound
04/19/2012US20120095090 Novel composition and method for stabilizing the same
04/19/2012US20120095089 Schweinfurthins and uses thereof
04/19/2012US20120095088 Medicinal cannabis uniform in food
04/19/2012US20120095087 Enhanced products by sustainable processes for medicinal use
04/19/2012US20120095086 Protein tyrosine phosphatase mutations in cancers
04/19/2012US20120095085 Nucleic acid modulators of clec-2
04/19/2012US20120095084 Modulation of serotonin neurons involving the pet-1 transcriptional control region
04/19/2012US20120095083 Use of triplex structure dna in transferring nucleotide sequences
04/19/2012US20120095082 Use of interfering rna for treating an hiv infection
04/19/2012US20120095081 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
04/19/2012US20120095080 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
04/19/2012US20120095079 Treatment of transcription factor e3 (tfe3) and insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to tfe3
04/19/2012US20120095078 Methods of diagnosis and treatment of melanoma
04/19/2012US20120095077 Methods and compositions related to modified guanine bases for controlling off-target effects in rna interference
04/19/2012US20120095076 Compositions and methods for inhibiting expression of huntingtin gene
04/19/2012US20120095075 Novel lipids and compositions for the delivery of therapeutics
04/19/2012US20120095074 Genetic Alterations on Chromosome 12 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes
04/19/2012US20120095073 Ion channel modulating activity ii
04/19/2012US20120095072 Crystalline Sodium Atorvastatin
04/19/2012US20120095071 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
04/19/2012US20120095070 Prevention and treatment of sarcopenia
04/19/2012US20120095069 Pharmaceutical oral telmisartan solution
04/19/2012US20120095068 Imidazolidine-2,4-dione derivatives and use thereof as a medicament
04/19/2012US20120095067 Pharmaceutical composition containing carboxylosartan and a production method therefor
04/19/2012US20120095066 Composition Comprising An Epothilone And Methods For Producing A Composition Comprising An Epothilone
04/19/2012US20120095065 Macrocyclic compounds and methods of treatment
04/19/2012US20120095064 (pyrazol-3-yl)-1,3,4-thiadiazol-2-amine and (pyrazol-3-yl)-1,3,4-thiazol-2-amine compounds
04/19/2012US20120095063 Methods and compositions for treatment of ischemic conditions and conditions related to mitochondrial function
04/19/2012US20120095062 Tricyclic compounds, compositions, and methods
04/19/2012US20120095061 Fluorinated Derivatives of Deferiprone
04/19/2012US20120095060 Methods and compositions of mitogen-activated protein kinase (mapk) pathway inhibitors for treating pulmonary fibrosis
04/19/2012US20120095059 Compositions and Methods for Treating Type II Diabetes and Related Disorders
04/19/2012US20120095058 Method of preventing survival of retrovirally cells and of inhibiting formation of infectious retroviruses
04/19/2012US20120095057 Pyrazole compound
04/19/2012US20120095056 2,5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulators
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120095054 Polymorphs of esomeprazole salts
04/19/2012US20120095053 Aminotetrahydroindazoloacetic acids
04/19/2012US20120095052 Par-1 antagonism in fed or antacid-dosed patients
04/19/2012US20120095051 Curcumin analogues as zinc chelators and their uses
04/19/2012US20120095050 Stabilized and preserved ketotifen ophthalmic compositions
04/19/2012US20120095049 Nociceptin analogs
04/19/2012US20120095048 Allosteric binding compounds
04/19/2012US20120095047 Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors
04/19/2012US20120095046 Amido-Isothiazole Compounds and Their Use as Inhibitors of 11Beta-HSD1 for the Treatment of Metabolic Syndrome and Related Disorders
04/19/2012US20120095045 Injectable anticancer composition for local administration containing hydroxychloroquine
04/19/2012US20120095044 Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
04/19/2012US20120095043 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
04/19/2012US20120095042 Organic Compounds Having Cooling Properties
04/19/2012US20120095041 Reversible nondepolarizing neuromuscular blockade agents and methods for their use
04/19/2012US20120095040 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof
04/19/2012US20120095039 Heterocyclic compounds with affinity to muscarinic receptors
04/19/2012US20120095038 Synthesis and anti-proliferative effect of benzimidazole derivatives
04/19/2012US20120095037 Synthesis and anti-proliferative effect of benzimidazole derivatives
04/19/2012US20120095036 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
04/19/2012US20120095035 Crystals of prasugrel hydrobromate
04/19/2012US20120095034 Piperidine derivatives useful as orexin receptor antagonists
04/19/2012US20120095033 Selective Glycosidase Inhibitors and Uses Thereof
04/19/2012US20120095032 Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same
04/19/2012US20120095031 Cyclopropane compound
1 ... 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 ... 7860